AVTX insider trading
Avalo Therapeutics, Inc.
In the past 36 days, 1 insider sold $382K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Christopher Ryan Sullivan Chief Financial Officer |
$202K 12,394 sh @ $16.33 |
−23.7% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Christopher Ryan Sullivan Chief Financial Officer |
$179K 10,185 sh @ $17.62 |
−20.3% | Pre-scheduled | Sep 10, 2026 Filed Sep 11, 2026 |